MedNet EC-REP GmbH to Exhibit at WHX 2026 in Dubai โ Visit Us at Booth S9.E77
MedNet EC-REP GmbH is excited to announce its participation in WHX 2026, taking place from February 9โ12 in Dubai. As a trusted European Authorized Representative and compliance partner for global medical device manufacturers, we look forward to presenting our comprehensive regulatory services to an international audience.
Showcasing Trusted EU Representation for Medical Devices and IVDs
At Booth S9.E77, MedNet EC-REP GmbH will showcase its full portfolio of regulatory compliance services, including:
- European Authorised Representative (EU-REP) under the MDR and IVDR
- UK Responsible Person (UKRP) services
- CH-REP support for Switzerland
- Regulatory Importer Services for Medical Devices & IVD`s
Our experts will be available throughout the exhibition to discuss regulatory pathways, documentation requirements, post-market obligations, and how MedNet EC-REP can support your market access strategy.
WHX Dubai is one of the leading global hubs for healthcare innovation and regulatory expertise. By visiting our booth, medical device and IVD manufacturers can gain clear insights into:
- Current MDR and IVDR expectations
- Upcoming regulatory changes impacting global manufacturers
- Streamlined solutions for entering the European and UK markets
- Efficient and compliant product lifecycle support
Whether you are preparing to launch a new device in Europe or seeking reliable regulatory representation, our team is ready to help you navigate complex compliance challenges.
Join Us in Dubai โ Booth S9.E77
We warmly invite you to meet our team at WHX 2026 in Dubai. Discover how MedNet EC-REP GmbH can support your regulatory strategy with professionalism, speed, and decades of expertise.
๐ Booth: S9.E77
๐
Date: February 09โ12, 20256
๐ Location: Dubai, UAE
We look forward to connecting with industry partners, customers, and innovators from around the world.
See you in Dubai!
Latest news
MHRA Introduces New Device Registration Fee: What Manufacturers Need to Know
The UKโs Medicines and Healthcare products Regulatory Agency (MHRA) has updated its โDORS Fees Guidance 2.1โ, introducing a new annual fee model for device registration.
EUDAMEDโs first four modules become mandatory on 28 May 2026 - what this means for medical device manufacturers
The European Commission (EC) has formally declared that the first four modules of EUDAMED - the European Database on Medical Devices - will become mandatory as of 28 May 2026.
Implications of the Update to the Borderline & Classification Manual under MDR and IVDR
On 12 September 2025, the European Commission published Version 4 of the Manual on Borderline and Classification under Regulations (EU) 2017/745 and 2017/746, developed by the Borderline and Classification Working Group (BCWG).
Regulatory Affairs Bulletin: Intended Purpose vs Intended Use under MDR & IVDR
European regulations EU 2017/745 (MDR) and EU 2017/746 (IVDR) require precise definitions in technical documentation, and the distinction (or overlap) between intended purpose and intended use remains a topic of operational significance.
-250x250.jpg&w=256&q=75)
MedNet EC-REP GmbH at MEDICA 2025 โ Visit Us in Hall 3, Booth D43
MedNet EC-REP GmbH is pleased to announce that we will once again be exhibiting at MEDICA 2025 in Dรผsseldorf, the worldโs leading trade fair for the medical technology industry.
EU eIFU Regulation Update Draft: What Medical Device Professionals Need to Know
The European Commission has introduced a significant amendment to Implementing Regulation (EU) 2021/2226, impacting how medical device manufacturers provide instructions for use (IFU).
Understanding the Interplay: MDR, IVDR, and the AI Act โ Key Insights from MDCG 2025-6
Recently, the MDCG, in conjunction with the Joint Artificial Intelligence Board (AIB), released the MDCG 2025-6 FAQ document, offering essential clarifications on the interplay between the MDR, the IVDR, and the Artificial Intelligence Act (AIA).